English | 繁體

Search in the results

UM

Browse/Search Results:  1-7 of 7 Help

Selected(0)Clear Items/Page:    Sort:
Real-World Utilization and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Dosed Weekly and Daily in Patients with Type 2 Diabetes Mellitus: Results from Retrospective Electronic Medical Records in China Journal article
Ruan, Zhen, Chen, Xianwen, Song, Menghuan, Jia, Ruxu, Luo, Hang, Ung, Carolina Oi Lam, Hu, Hao. Real-World Utilization and Effectiveness of Glucagon-Like Peptide-1 Receptor Agonists Dosed Weekly and Daily in Patients with Type 2 Diabetes Mellitus: Results from Retrospective Electronic Medical Records in China[J]. Diabetes, Metabolic Syndrome and Obesity, 2024, 17, 3657-3666.
Authors:  Ruan, Zhen;  Chen, Xianwen;  Song, Menghuan;  Jia, Ruxu;  Luo, Hang; et al.
Favorite | TC[WOS]:0 TC[Scopus]:0  IF:2.8/3.3 | Submit date：2024/11/05
Type 2 Diabetes Mellitus  Glucagon-like Peptide-1 Receptor Agonist  Glp-1ra  Retrospective  China  Electronic Medical Record  Real-world  
Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review Journal article
Zhen Ruan, Yixuan Jiang, Honghao Shi, Ruxu Jia, Carolina Oi Lam Ung, Hao Hu. Real-world clinical effectiveness of once-weekly semaglutide in patients with type 2 diabetes: a systematic literature review[J]. Expert Review of Clinical Pharmacology, 2023, 16(2), 161-176.
Authors:  Zhen Ruan;  Yixuan Jiang;  Honghao Shi;  Ruxu Jia;  Carolina Oi Lam Ung; et al.
Favorite | TC[WOS]:4 TC[Scopus]:3  IF:3.6/4.1 | Submit date：2023/08/03
Effectiveness  Glp-1ra  Hba1c  O.w. Semaglutide  Type 2 Diabetes  Real-world Evidence  Review  Weight  
Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China Journal article
Liu, Lei, Ruan, Zhen, Ung, Carolina Oi Lam, Zhang, Yawen, Shen, Yang, Han, Sheng, Jia, Ruxu, Qiao, Jingtao, Hu, Hao, Guo, Lixin. Long-Term Cost-Effectiveness of Subcutaneous Once-Weekly Semaglutide Versus Polyethylene Glycol Loxenatide for Treatment of Type 2 Diabetes Mellitus in China[J]. Diabetes Therapy, 2023, 14(1), 93-107.
Authors:  Liu, Lei;  Ruan, Zhen;  Ung, Carolina Oi Lam;  Zhang, Yawen;  Shen, Yang; et al.
Favorite | TC[WOS]:6 TC[Scopus]:8  IF:2.8/2.9 | Submit date：2023/01/08
Cost-effectiveness Analysis  Type 2 Diabetes  Glucagon-like Peptide-1 Analogue  Semaglutide  Peg-loxenatide  China  
Different Associations Between CDKAL1 Variants and Type 2 Diabetes Mellitus Susceptibility: A Meta-analysis Journal article
Zeng, Qiaoli, Zou, Dehua, Gu, Shanshan, Han, Fengqiong, Cao, Shilin, Wei, Yue, Guo, Runmin. Different Associations Between CDKAL1 Variants and Type 2 Diabetes Mellitus Susceptibility: A Meta-analysis[J]. Frontiers in Genetics, 2022, 12.
Authors:  Zeng, Qiaoli;  Zou, Dehua;  Gu, Shanshan;  Han, Fengqiong;  Cao, Shilin; et al.
Favorite | TC[WOS]:3 TC[Scopus]:4  IF:2.8/3.3 | Submit date：2023/01/30
Cdkal1  Meta-analysis  Polymorphisms  Susceptibility  Type 2 Diabetes Mellitus  
Small molecule IVQ, as a prodrug of gluconeogenesis inhibitor QVO, efficiently ameliorates glucose homeostasis in type 2 diabetic mice Journal article
Ting-ting Zhou, Tong Zhao, Fei Ma, Yi-nan Zhang, Jing Jiang, Yuan Ruan, Qiu-ying Yan, Gai-hong Wang, Jin Ren, Xiao-wei Guan, Jun Guo, Yong-hua Zhao, Ji-ming Ye, Li-hong Hu, Jing Chen, Xu Shen. Small molecule IVQ, as a prodrug of gluconeogenesis inhibitor QVO, efficiently ameliorates glucose homeostasis in type 2 diabetic mice[J]. ACTA PHARMACOLOGICA SINICA, 2019, 40(9), 1193-1204.
Authors:  Ting-ting Zhou;  Tong Zhao;  Fei Ma;  Yi-nan Zhang;  Jing Jiang; et al.
Adobe PDF | Favorite | TC[WOS]:5 TC[Scopus]:6  IF:6.9/7.6 | Submit date：2020/04/14
Type 2 Diabetes Mellitus  Hepatic Gluconeogenesis  Ampk Signaling Pathway  (e)-3-(2-(Quinoline-4-yl)Vinyl)-1h-indol-6-ol (Qvo)  4-[2-(1h-indol-3-yl)Vinyl]Quinoline (Ivq)  Prodrug  
In vitro Vitamin K2 and 1α,25-dihydroxyvitamin D3 combination enhances osteoblasts anabolism of diabetic mice Journal article
Christina C.W. Poon, Rachel W.S. Li, Sai Wang Seto, Siu Kai Kong, Ho Pui Ho, Maggie P.M. Hoi, Simon M.Y. Lee, Sai Ming Ngai, Shun Wan Chan, George P.H. Leung, Yiu Wa Kwan. In vitro Vitamin K2 and 1α,25-dihydroxyvitamin D3 combination enhances osteoblasts anabolism of diabetic mice[J]. European Journal of Pharmacology, 2015, 767, 30-40.
Authors:  Christina C.W. Poon;  Rachel W.S. Li;  Sai Wang Seto;  Siu Kai Kong;  Ho Pui Ho; et al.
Favorite | TC[WOS]:28 TC[Scopus]:28  IF:4.2/4.3 | Submit date：2018/11/06
1,25(Oh)2d3  Osteoblasts  Osteoporosis  Type 2 Diabetes Mellitus  Vitamin K2  
Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in prevention of autoimmune diabetes in non-obese diabetic mice treated with α-galactosylceramide Journal article
Li W., Ji F., Zhang Y., Wang Y., Yang N., Ge H., Wang F.. Cooperation of invariant NKT cells and CD4+CD25+ T regulatory cells in prevention of autoimmune diabetes in non-obese diabetic mice treated with α-galactosylceramide[J]. Acta Biochimica et Biophysica Sinica, 2008, 40(5), 381-390.
Authors:  Li W.;  Ji F.;  Zhang Y.;  Wang Y.;  Yang N.; et al.
Favorite | TC[WOS]:12 TC[Scopus]:12 | Submit date：2019/01/16
Α-galactosylceramide  Foxp3  Invariant Nkt Cell  Treg  Type 1 Diabetes